Artificial intelligence systems are beginning to function as “co-scientists” in cancer research, generating drug candidates, prioritizing immunotherapy targets, and guiding experimental design.
2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...
Cancer Discov (2026) 16 (2): OF1.
Researchers used a unique base-editing strategy to engineer chimeric-antigen receptor (CAR) T cells that engraft in the host and remain invisible to remaining antibody drugs. Of the 11 patients with T ...
1Department of Pathology, University Hospital Toulouse, Cancer Research Center of Toulouse, Labex TOUCAN, Toulouse, France.
While immune checkpoint blockade has become a cornerstone of cancer therapy, treatment responses can be transient, and the disease often relapses. In this study, Guo, Luan, and colleagues explored the ...
1Rutgers Cancer Institute, New Brunswick, New Jersey. *Corresponding Author: Sharon L. Manne, Rutgers Cancer Institute, 120 Albany Street, Tower 2, Floor 8, New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results